Thanks! You've successfully subscribed to the BONEZONE®/OMTEC® Monthly eNewsletter!

Please take a moment to tell us more about yourself and help us keep unwanted emails out of your inbox.

Choose one or more mailing lists:
BONEZONE/OMTEC Monthly eNewsletter
OMTEC Conference Updates
Advertising/Sponsorship Opportunities
Exhibiting Opportunities
* Indicates a required field.

Stryker Enters Definitive Agreement to Acquire Mobius Imaging and Cardan Robotics

To bolster its spine division, Stryker is acquiring Mobius Imaging and its sister company, Cardan Robotics. The deal is a cash transaction of $500MM (approximately $370MM upfront, plus $130MM in contingent and milestone payments). The acquisition provides Stryker with immediate entry into the intra-operative imaging segment to complement its implant and navigation offerings. The purchase is expected to close in 4Q19.

Mobius Imaging is focused on integrating advanced imaging technologies in the surgical workflow. Their FDA 510(k)-cleared Airo TruCT scanner provides real-time diagnostic quality CT imaging. Cardan Robotics had been developing robotics and navigation systems for surgical and interventional radiology procedures, specifically, the Orion spinal robotic system comprising a custom surgical robot, surgical table, table-mounted surgical robot, portable CT scan, navigation, etc.

"This acquisition brings expertise in advanced imaging and robotics as well as a robust product pipeline that add to Stryker’s portfolio and will allow the Spine division to provide more complete procedural solutions, including sales, service, and support," said Spencer Stiles, Stryker’s Group President, Orthopaedics and Spine. "We look forward to working together to advance Stryker’s mission to make healthcare better and accelerate our pursuit of category leadership in Neurotechnology, Orthopaedics, and Spine."

ORTHOWORLD estimates rank Stryker as the third-largest player by revenue in the spine segment with an estimated $781.3MM in revenue for 2018. NuVasive, Stryker and Globus comprise a core of high-growth secondary players in the spine market, all with organic spine sales growth of +9% or better in 2018 vs. the prior year. All three companies have carried positive momentum for spine sales through the first half of 2019.

As orthopedic sales strategies increasingly focus on end to end solutions instead of single implants, this acquisition serves to give Stryker a more complete array of whole-procedure solutions that cover sales, service and support. While Stryker reinvigorated their spine product offerings with the acquisition of K2M last year, it is clear that they felt the need to be aggressive in transactions to level the playing field with NuVasive and Globus. Such activity also continues a trend of companies purchasing technologies that have already been developed and commercialized.